Monitor for actual execution of the sale; given the officer's repeated transactions and prior sales, this appears to be part of a planned liquidity strategy rather than a signal of distress. However, continued insider selling could weigh on sentiment if volume accelerates.
Price Chart
Executive Summary
Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to notify intent to sell up to 10,000 shares, valued at approximately $300,000 based on current market prices. This follows a series of prior stock option exercises and sales totaling over $1.15 million in the past two months.
Key Facts
- Reporting owner: Elizabeth E. Reed, Officer of Travere Therapeutics
- Shares proposed for sale: 10,000 common shares
- Approximate value of proposed sale: $300,000 (based on $30/share)
- Sale to be conducted through Morgan Stanley Smith Barney LLC
- Recent insider activity includes $1.15M in prior sales by Reed in February–March 2026
Financial Impact
$300,000 proposed sale, part of ongoing insider disposition pattern
Risk Factors
- Perception of insider lack of confidence if selling continues amid flat stock performance
- Potential for increased near-term selling pressure if lock-up periods are expiring or options are vesting
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003118 |
| Document: 0001950047-26-003118-index.html | 0001950047-26-003118 |
| Document: 0001950047-26-003118.txt | 0001950047-26-003118 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 8-K | $56.59 $61.32 | ▲ +8.36% | ▲ +5.93% | $56.93 (+0.60%) |
Jun 16, 2026 15w ago | Insider Cluster | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 16, 2026 15w ago | 8-K | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 12, 2026 16w ago | 144 | $52.04 $56.59 | ▲ +8.74% | ▲ +6.96% | $56.93 (+9.40%) |
Jun 2, 2026 17w ago | 8-K | $42.96 $56.34 | ▲ +31.15% | ▲ +32.71% | $56.93 (+32.52%) |
May 15, 2026 20w ago | 144 | $42.59 $53.80 | ▲ +26.32% | ▲ +24.20% | $56.93 (+33.67%) |
May 5, 2026 21w ago | 144 | $44.76 $45.20 | ▲ +0.98% | ▼ −1.80% | $56.93 (+27.19%) |
May 4, 2026 21w ago | 144 | $44.80 $42.96 | ▼ −4.11% | ▼ −9.06% | $56.93 (+27.08%) |
May 1, 2026 22w ago | Insider Cluster | $44.12 $45.04 | ▼ −2.09% | ▲ +3.20% | $56.93 (−29.03%) |
Apr 15, 2026 24w ago | 144 | $40.95 $42.84 | ▲ +4.62% | ▼ −1.43% | $56.93 (+39.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access